Home/Nektar Therapeutics/Jonathan Zalevsky
JZ

Jonathan Zalevsky

Chief Research & Development Officer

Nektar Therapeutics

Nektar Therapeutics Pipeline

DrugIndicationPhase
RezpegaldesleukinAtopic DermatitisPhase 2b
NKTR-0165Ulcerative Colitis, Vitiligo, Multiple SclerosisPreclinical